| ALT | Alanine aminotransferase (glutamic-pyruvic transaminase, GPT) |
| ALP | Alkaline phosphatase |
| AST | Aspartate amino-transferase (glutamic-oxalo-acetic transaminase, GOT) |
| AUC | Area under the curve |
| BCAA | Branched chain amino acids |
| CB | Conjugated (direct) bilirubin |
| CCL2 (MCP-1) | Metalloproteinase 1 |
| CCL5 (RANTES) | Regulated upon activation, normal T cell expressed and presumably secreted |
| CCR5 | Ligand (MIP)- macrophage inflammatory protein -1 |
| CIOMS | Council for International Organizations of Medical Sciences |
| DILI | Drug-induced liver injury |
| ECM | Extracellular matrix |
| ELISA | Enzyme-linked immunosorbent assay |
| GGT | γ-glutamyl-transferase (γ-glutamyl-transpeptidase, GGTP) |
| HILI | Herbal-induced liver injury |
| IFNβ | Interferon beta |
| IFN γ | Interferon gamma |
| IL | Interleukin: IL1-α IL1β, IL2, IL4, IL6, IL8, IL 15 |
| INR | International Normalized Ratio |
| LTA | Lymphocyte toxicity assay |
| MMP | Matrix metalloprotease |
| MTT | 3-(4,5-dimethyl-thiazol-2-yl)-2,5-dio-phenyl tetrazolium bromide |
| NFκB | Nuclear factor κ-B (transcription factor) |
| NKT | Natural killer cells |
| PDGF | Platelet-derived growth factor |
| RUCAM | Roussel Uclaf Causality Assessment Method |
| SDH | Succinate dehydrogenase |
| TGF | β Transforming growth factor beta |
| TLR | Tall like receptor |
| TNFα | Tumor necrosis factor alpha |
| TRAIL | Tumor necrosis factor related apoptosis-inducing ligand-(APO-2L) |
| ULN | Upper limit of the normal reference range |
| VEGF | Vascular endothelial growth factor |
| Acute inflammation | elevated CCL5 (RANTES), IL1–α, IL1–β, IL6, IL8, IL-15, TNF–α |